Page last updated: 2024-09-05

sb 203580 and mitopodozide

sb 203580 has been researched along with mitopodozide in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(mitopodozide)
Trials
(mitopodozide)
Recent Studies (post-2010) (mitopodozide)
3,48941,1376620

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodbeck, K; Häring, HU; Pfeiffer, A; Sauer, U; Schleicher, ED; Weigert, C1

Other Studies

1 other study(ies) available for sb 203580 and mitopodozide

ArticleYear
AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells.
    Journal of the American Society of Nephrology : JASN, 2000, Volume: 11, Issue:11

    Topics: Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Glomerular Mesangium; Glucose; Humans; Hyperglycemia; Imidazoles; Indoles; Maleimides; Mitogen-Activated Protein Kinases; Nuclear Proteins; p38 Mitogen-Activated Protein Kinases; Podophyllin; Podophyllotoxin; Promoter Regions, Genetic; Pyridines; RNA, Messenger; Sp1 Transcription Factor; Tetradecanoylphorbol Acetate; Tissue Distribution; Transcription Factor AP-1; Transforming Growth Factor beta; Transforming Growth Factor beta1

2000